We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 496.00
Bid: 492.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 8.00 (1.626%)
Open: 496.00
High: 496.00
Low: 496.00
Prev. Close: 496.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

30 Apr 2020 12:41

RNS Number : 5196L
B.P. Marsh & Partners PLC
30 April 2020
 

30th April 2020 

 

 

B.P. Marsh & Partners Plc 

("B.P. Marsh", "the Company" or "the Group") 

 

Portfolio Update

 

Repayment of Loan:

B.P. Marsh (AIM: BPM), the specialist investor in early stage financial services businesses, is pleased to note the recent receipt of a £2m Loan Repayment from Nexus Underwriting Management Limited ("Nexus").

 

The Company provided Nexus with a £2m Revolving Credit Facility in April 2019 (the "Loan Facility") as part of a wider £16m fundraising exercise, alongside the global investment firm HPS Investment Partners LLC. This was undertaken in order to provide Nexus with sufficient capital to pursue its growth strategy via value accretive acquisitions.

 

The Loan Facility was drawn down in full and has now been repaid by Nexus, eight months earlier than the scheduled repayment date. The Loan Facility will remain in place until December 2020.

 

The Loan Facility is in addition to a further £4m facility that the Group provided to Nexus in July 2017, which is due for repayment by January 2024.

 

The Group holds an aggregate Nexus shareholding of 17.6%, having bought an initial shareholding of 5% in August 2014. Since the Group's initial investment, Nexus has become one of the largest independently owned Managing General Agencies in the UK insurance market, growing from approximately £50m of premium income in 2014 to a budgeted £345m of premium income in 2020. This premium income is generated across various specialty areas including Financial Lines, Reinsurance, Trade Credit, Marine and Aviation insurance.

 

When the Group made its first investment in Nexus, it was operating one London office. Nexus now has offices in 9 countries across Europe, America and Asia.

 

In addition, on 9th  March 2020 Nexus announced that its independent broking arm, Xenia Broking Group Limited ("Xenia"), completed the acquisition of the trade credit business of Howden UK Group Limited ("Howden"), part of Hyperion Insurance Group Ltd. Xenia will integrate Howden's trade credit business with its existing trade credit broking operations, making it one of the largest independent trade credit insurance brokers in the UK.

 

Chief Investment Officer, Daniel Topping, commented on the repayment: "Given the unprecedented challenges currently faced by the UK and Global economies, it is testament to the strength of Nexus, its management and entire team that it is able, not only to continue to pursue its growth strategy via the acquisition of Howden's trade credit business, but also that it is able to access funding on commercially favourable terms.

 

"Nexus is not immune to the impact of Covid-19, but the Group has been pleased by the response of everyone at Nexus to adapt to these challenges and work towards solidifying the long-term strength of Nexus. At B.P. Marsh we have been pleased to see this approach replicated throughout our portfolio. Whilst it is currently difficult to provide long-term impact forecasts, we believe the approach taken by our portfolio's management teams has been sensible and proportionate, and underpins our long-term partnership-led approach to investment."

 

Covid-19:

B.P. Marsh continues to monitor closely the ongoing impact of the current Covid-19 pandemic. Whilst it is too early to predict with any accuracy the long-term impact, the Group's management team is working closely with each portfolio company and its management to ensure that each of them is well positioned to mitigate the short term impact of this situation.

 

At this juncture, the Group believes each portfolio company is adequately resourced to weather the challenges currently presented by Covid-19. The Group is focussed on cash flow and considers that it has sufficient resources available, including the £2m loan repayment from Nexus, together with access to a £3m loan facility, to support investee companies if necessary. 

 

We continue to operate effectively, with all management and employees working remotely. This shift in our working arrangements has not presented any significant challenges, as the team was already in the habit of liaising with portfolio companies across multiple locations and time zones. Our portfolio companies have also implemented remote working arrangements and have demonstrated that earlier investment into systems and business continuity plans have enabled these arrangements to be implemented with minimal impact.

 

Annual Results:

B.P. Marsh anticipates that it will publish its Annual Results on 9th June 2020 as previously announced. The Group will provide a further update on the impact of Covid-19 within the Annual Results. 

 

For further information, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Sinead O'Haire

 

+44 (0)20 7233 3112

Panmure Gordon (UK) Limited

Atholl Tweedie / Charles Leigh Pemberton / Ailsa MacMaster

 

+44 (0)20 78862500

Tavistock

Jos Simson / Simon Hudson / Tim Pearson

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

Notes to Editors: 

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk. 

 

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years. 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUBBGDSCXXDGGG
Date   Source Headline
16th Apr 202412:45 pmRNSInvestee Company Update – LEBC Holdings
12th Apr 202411:01 amRNSAward of Shares under Share Incentive Plan
9th Apr 20249:45 amRNSInvestment Update – Pantheon Specialty Limited
8th Apr 20243:07 pmRNSTransfer of Treasury Shares
27th Mar 202412:20 pmRNSInvestment – Devonshire UW Limited
25th Mar 20247:00 amRNSCompletion of Sale and Dividend Declaration
22nd Feb 202410:49 amRNSDirector/PDMR Shareholding
19th Feb 20244:05 pmRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSTrading Update
16th Feb 20244:13 pmRNSDirector/PDMR Shareholding
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
13th Feb 20241:52 pmRNSHolding(s) in Company
9th Feb 20249:25 amRNSDirector/PDMR Shareholding
7th Feb 20243:00 pmRNSInterim Dividend Declaration
6th Feb 202412:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20242:23 pmRNSUse of Proceeds of Sale and Strategy Confirmation
4th Jan 20244:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:25 amRNSInvestment – Ai Marine Risk Limited
27th Dec 20237:00 amRNSCorrection - PDMR and Director Dealings
8th Dec 20235:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:23 amRNSRealisation of Investment
4th Dec 202310:58 amRNSTransaction in Own Shares
30th Nov 202312:56 pmRNSTransaction in Own Shares
29th Nov 20232:29 pmRNSTransaction in Own Shares
27th Nov 202312:48 pmRNSTransaction in Own Shares
24th Nov 20234:15 pmRNSTransaction in Own Shares
23rd Nov 20234:55 pmRNSTransaction in Own Shares
20th Nov 202312:35 pmRNSFurther Information re Share Option Plan
20th Nov 202311:44 amRNSTransaction in Own Shares
15th Nov 20235:33 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSShares Cancellation & New Share Buy-Back Programme
13th Nov 20239:42 amRNSInvestee Company Update disposal by LEBC of Aspira
20th Oct 20236:23 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares
25th Sep 202310:28 amRNSTransaction in Own Shares
19th Sep 20233:50 pmRNSTransaction in Own Shares
18th Sep 202311:18 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTrading Statement
14th Sep 20232:49 pmRNSTransaction in Own Shares
11th Sep 20234:29 pmRNSTransaction in Own Shares
7th Sep 20235:32 pmRNSTransaction in Own Shares
5th Sep 20234:24 pmRNSTransaction in Own Shares
4th Sep 20232:48 pmRNSTransaction in Own Shares
1st Sep 20233:13 pmRNSTransaction in Own Shares
30th Aug 20231:58 pmRNSTransaction in Own Shares
29th Aug 20239:03 amRNSTransaction in Own Shares
24th Aug 202312:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.